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Abstract 17 
The POU1F1 (Pit-1) transcription factor is important in regulating expression of 18 
growth hormone, prolactin and TSH -subunit, and controlling development of 19 
the anterior pituitary cells in which these hormones are produced.  POU1F1 is a 20 
conserved protein comprising three main domains, an N-terminal transcription 21 
activation domain (TAD), a POU-specific domain and a C-terminal 22 
homeodomain.  Within the TAD, a -domain can be inserted by alternative 23 
splicing, giving an extended '-variant' with altered properties.  Here sequence 24 
data from over 100 species were used to assess the variability of POU1F1 in 25 
mammals. This showed that the POU-specific domain and homeodomain are 26 
very strongly conserved, and that the TAD is somewhat less conserved, as are 27 
linker and hinge regions between these main domains. On the other hand, the -28 
domain is very variable, apparently evolving at a rate not significantly different 29 
from that expected for unconstrained, neutral evolution.  In several species stop 30 
and/or frameshift mutations within the -domain would prevent expression of the 31 
-variant as a functional protein. In most species expression of the -variant is 32 
low (<5% of total POU1F1 expression).  The rate of evolution of POU1F1 in 33 
mammals shows little variation, though the lineage leading to dog does show an 34 
episode of accelerated change. This comparative genomics study suggests that in 35 
most mammalian species  POU1F1 variants produced by alternative splicing may 36 
have little physiological significance.37 
 3 
1. Introduction 38 
The transcription factor POU1F1 (Pit-1, GHF-1) plays a crucial part in regulating 39 
the development of the anterior pituitary gland and the expression of specific 40 
pituitary hormones. Mutations in the POU1F1 gene can lead to failure of the 41 
development of cells expressing growth hormone (GH), prolactin and TSH in 42 
mice and humans (Andersen and Rosenfeld, 2001; Cohen and Radovick 2002; 43 
Kelberman et al., 2009; Li et al., 1990; Radovick et al., 1992). The expression of 44 
GH, prolactin and the -subunit of TSH is regulated by POU1F1, and promoters 45 
for genes encoding these hormones, POU1F1 itself, and various associated 46 
proteins, contain binding sites for POU1F1 (Baumeister et al., 2000; Chen et al., 47 
1990; Ellestad and Porter, 2013; Featherstone et al., 2012; Fox et al., 1990; 48 
Herman et al., 2012; Nowakowski and Maurer, 1994; Scully et al., 2000). In the 49 
adult, POU1F1 is expressed at high levels in somatotropes, lactotropes and 50 
thyrotropes.  It is expressed in most other cell types at very low levels if at all, 51 
though significant expression has been reported in human placenta, hemopoietic 52 
and lymphoid tissues, and mammary gland (Bamberger et al., 1995; Delhase et 53 
al., 1993; Gil-Puig et al., 2005).  Expression levels in breast tumours, and 54 
tumour-derived cell lines are often higher than those in normal breast tissue, and 55 
appear to be associated with enhanced proliferation and metastasis (Gil-Pig et al., 56 
2005; Ben-Batalla et al., 2010). 57 
 58 
POU1F1 is a member of the POU family of transcription factors, and like other 59 
members of the family has a multi-domain structure, with an N-terminal 60 
transcription activation (TAD) domain, a POU-specific domain and a C-terminal 61 
homeodomain (Theill et al., 1989) (Fig. 1). These domains are strongly 62 
 4 
conserved, whereas the regions between them, postulated to comprise flexible 63 
linkers, are more variable (Majumdar et al., 1996; Morris et al., 1992; Theill et 64 
al., 1989). An additional region, the -domain, can be inserted within the TAD as 65 
a consequence of alternative splicing, two splice forms occurring in which the -66 
domain is present or absent (Delhase et al., 1995; Morris et al., 1992; Theill et 67 
al., 1992). The two splice variants in mammals have substantially different 68 
biological properties which have been studied extensively (Diamond and 69 
Gutierrez-Hartmann, 1996, 2000; Jonsen et al., 2009; Sánchez-Pacheco et al., 70 
1998; Sporici et al., 2005), but their physiological roles are not well defined. 71 
Additional splice variants of POU1F1 have been described in sheep (Bastos et 72 
al., 2006), but it is unclear whether these play a specific biological role. 73 
 74 
The view that the domains in POU1F1 are strongly conserved is based on a 75 
relatively small number of mammalian and non-mammalian species. The 76 
availability of genomic data from over 100 mammalian species, including most 77 
of the extant taxonomic orders, makes possible a much fuller study of POU1F1 78 
variation in mammals and its evolutionary significance. The availability of 79 
transcriptomic data for a number of species allows evaluation of POU1F1 splice 80 
variation across mammals. Such a study is reported here. Questions addressed 81 
include 1) are the POU1F1 domain sequences strongly conserved across all 82 
mammals? 2) is there evidence for variable rates of evolution as seen for the 83 
target genes of POU1F1, GH and prolactin (Li et al., 2005; Wallis, 1996, 2008; 84 
Wallis et al., 2000)?  3) To what extent are splice variations in the POU1F1 gene 85 
conserved across mammals, especially with regard to the form containing the -86 
domain (the -variant)?  87 
 5 
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 89 
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2. Methods 92 
 93 
2.1. Sequences 94 
cDNA sequences for POU1F1 from various mammals were obtained by 95 
searching the publically available ncbi nucleotide database using BLAST 96 
(Altschul et al., 1990) with human POU1F1 -variant cDNA as Query. In all 97 
cases they were checked against appropriate wgs or sra databases 98 
(https://trace.ncbi.nlm.nih.gov) using BLAST. Additional sequences were 99 
obtained by searching sra databases using BLAST and sequences from related 100 
species. Sequences were aligned in Mesquite (Maddison and Maddison, 2016) 101 
and translated to protein sequences. Sources for all the sequences used and full 102 
CDS and protein alignments are given in Supplementary Table 1 and 103 
Supplementary Figs. 1 and 2.  Domains within sequences were assigned on the 104 
basis of Fig. 1. 105 
 106 
2.2. Sequence analysis - evolutionary rates 107 
To analyse evolutionary rates of different regions within the POU1F1 CDS 108 
sequences, the codeml programme in the paml package (Phylogenetic Analysis 109 
by Maximum Likelihood; Yang, 2007) was used to determine the ratio (dN/dS) 110 
of nonsynonymous substitutions (which alter amino acid sequence) to 111 
synonymous substitutions (which do not). For most coding sequences dN/dS is 112 
low, reflecting maintenance of functional sequence by purifying selection. For a 113 
sequence with little or no specific function dN/dS approaches 1.0, the neutral rate 114 
of evolution. If dN/dS is significantly greater than 1.0, the sequence is 115 
undergoing rapid adaptive evolution by natural selection, though a value lower 116 
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than 1.0 does not necessarily rule out adaptive evolution. 117 
 118 
Alignments of CDS sequences corresponding to all or subregions of the POU1F1 119 
mRNA were analysed using the codeml method (Yang, 2007), using a defined 120 
phylogenetic tree. Significance of differences between dN/dS ratios was tested 121 
using the likelihood ratio test (Yang, 2007). 122 
 123 
2.3. Splicing patterns 124 
Splicing patterns for the POU1F1 gene were determined by analysing 125 
transcriptomes available for various species through the sra database 126 
(https://trace.ncbi.nlm.nih.gov/Traces/sra). In each case, POU1F1-related 127 
sequences were identified using BLAST with the appropriate CDS as query, and 128 
analysed to identify hits overlapping splice junctions. 129 
 130 
131 
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3. Results and Discussion 132 
 133 
3.1. POU1F1 Sequences 134 
Complete POU1F1 coding sequences were derived for a total of 113 mammalian 135 
species. Analysing all these sequences together using codeml took an excessively 136 
long time, and they were therefore divided into subgroups: (1) subgroup 1 137 
including representatives from each of the main mammalian groups (38 spp), (2) 138 
primates, tree shrew and flying lemur (32 spp), (3) rodents and lagomorphs (19 139 
spp), (4) Laurasiatheria (48 spp), (5) Xenarthra, Afrotheria, Marsupialia and 140 
Prototheria (14 spp). Individual species included in each of these groups (plus 141 
outgroups) are indicated in the sequence alignments given in Supplementary 142 
Figs. 1 and 2.  143 
 144 
In no species was there clear evidence for more than one POU1F1 gene. 145 
However, in several cases there was evidence of polymorphism, and in some of 146 
these it is conceivable that this could reflect the presence of two very similar 147 
(duplicate) genes rather than polymorphisms.  In all such cases intra-specific 148 
variation was less than between-species variation (based on comparison with 149 
closely related species), so the analysis would not be affected. 150 
 151 
Alignment of POU1F1 sequences was straightforward, with only a few insertions 152 
or deletions (indels) required.  Visual assessment of alignments (Supplementary 153 
Fig. 2) indicated that the POU-specific and homeodomain domains are very 154 
strongly conserved, as suggested previously on the basis of comparison of a few 155 
species (Majumdar et al., 1996; Morris et al., 1992; Theill et al., 1989), and that 156 
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linker and hinge regions and the TAD are rather more variable. The -domain is 157 
very variable, particularly at the C-terminal end (Fig. 2). The sequence of dog 158 
POU1F1 shows rather high variation, especially in the TAD and hinge region.  159 
 160 
3.2. Rates of Evolution 161 
3.2.1. Complete POU1F1 162 
Analysis of the POU1F1 CDS alignment for subgroup 1 (including -domain) by 163 
the codeml method gave a dN/dS ratio of 0.085, showing that the protein overall 164 
is fairly strongly conserved (Table 1). Similar results were obtained for the other 165 
subgroups. However, as noted above, some domains appear to be more strongly 166 
conserved than others, so this value is an average; individual domains/regions are 167 
considered separately below. Codeml analysis also indicated that there was 168 
significant variation in dN/dS between species; this was largely due to an 169 
increased rate of evolution on the lineage leading to dog, for which branch dN/dS 170 
was significantly elevated (0.18; P<0.05, likelihood ratio test). 171 
 172 
3.2.2. POU-specific domain and homeodomain 173 
Analysis of the POU-specific domain and homeodomain, separately, using 174 
codeml gave very low values for dN/dS (Table 1), confirming the strong 175 
conservation deduced from visual inspection and previous reports. There was no 176 
evidence for rate variation between species, including dog. 177 
 178 
3.2.3. TAD 179 
Analysis of the TAD (excluding -domain) by codeml gave values for dN/dS 180 
(0.084 for subgroup 1) similar to that obtained for POU1F1 overall (Table 1), 181 
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indicating that this domain is fairly strongly conserved, but less so than the 182 
homeodomain or POU-specific domain. Again, there was no evidence for rate 183 
variation between species; dN/dS was elevated on the branch leading to dog, but 184 
not significantly. 185 
 186 
3.2.4. Hinge and linker regions 187 
The hinge region between TAD and POU-specific domain is rather more variable 188 
than either of these, with dN/dS 0.146. Similarly, the short linker region (dN/dS 189 
0.052) is more variable than its flanking POU-specific and homeodomains (Table 190 
1). Nevertheless, both these sequences are quite strongly conserved. Neither 191 
shows evidence for rate variation between species. 192 
 193 
3.2.5. C-terminal tail 194 
The short C-terminal tail is rather variable. Indels in some species, and truncation 195 
in marsupials make detailed analysis difficult. 196 
 197 
-domain  198 
Analysis of the -domain by codeml (alignment for subgroup 1) gave a high 199 
value for dN/dS of 0.91, and similarly high values were obtained with alignments 200 
for other subsets of sequences (Table 1). In no case was the value significantly 201 
different from 1.0. This corresponds to the ratio expected for a sequence evolving 202 
by neutral evolution, unconstrained by the purifying selection imposed by 203 
functional constraints. This suggests, but does not prove, lack of function for this 204 
specific protein sequence - elevated evolutionary rate could also be due to 205 
positive selection (with dN/dS not necessarily exceeding 1.00), although in this 206 
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case one might expect to see rate variation between groups or species, which is 207 
not apparent.  208 
 209 
However, lack of function of the -domain (and presumably therefore the -210 
variant of POU1F1) is also indicated by the presence in some species of 211 
mutations in this domain which would prevent expression of the intact protein 212 
(Fig. 2). Thus in a prosimian (Daubentonia madagascariensis; aye aye) and an 213 
afrotherian (Elephantulus edwardii; elephant shrew) a stop codon in the sequence 214 
encoding the -domain would prevent translation of the following sequence 215 
(including POU specific domain and homeodomain). In the New World monkey 216 
marmoset (three species, Callithrix jacchus, C. kuhlii and C. geoffroyi) there are 217 
two separate deletions in the -domain, of two and one nucleotides respectively; 218 
between these the reading frame is changed, with introduction of a stop codon. In 219 
the related New World monkey tamarin (Saguinas midas) just one of these 220 
deletions occurs, changing the reading frame of the rest of the protein. In 221 
pangolin (Manolis pentadactyla) insertion of two nucleotides into the -domain 222 
sequence would again change the reading frame for the rest of the protein. 223 
 224 
As has been noted previously (Diamond & Gutierrez-Hartmann 1996) the N-225 
terminal half of the -domain is more conserved than the C-terminal half. 226 
However, examination of the CDS alignment shows that this applies to the non-227 
coding nucleotide sequence as well as the protein sequence; the high dN/dS value 228 
for this region is due to low dS as well as high dN. Exceptions to high 229 
conservation of this region are guinea pig, elephant shrew and tenrec.  The C-230 
terminal end of the -domain corresponds to the 14-residue insert found in the 231 
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Pit-1T variant, specific to thyrotropes (Haugen et al., 1993) and here too a high 232 
dN/dS value suggests lack of specific function. The deletions noted above in the 233 
-domain for marmoset and tamarin fall in this region, and would be expected to 234 
prevent expression of a functional Pit-1T, but the stop codons in the -domain af 235 
aye-aye and elephant shrew fall upstream of this region. 236 
 237 
In the marsupial and monotreme species for which data are available, 238 
substitutions at the 3' end of the -domain-encoding sequence alter the ..AG 239 
required for this sequence to be spliced out. However, a potential alternative 240 
splice site is introduced 3 nucleotides into exon 2. Analysis of available 241 
transcriptomic data for opposum (Monodelphis domestica; low expression of 242 
POU1F1 seen in transcriptomes from various tissues and whole newborn, but not 243 
available for isolated pituitary) indicates that this is used in most cases (the -244 
domain is retained in only one of 12 instances identified). For other marsupials 245 
and for monotremes the available transcriptomic data give no useful information 246 
on this aspect.  247 
 248 
3.2.7. Variation of evolutionary rate between groups and species 249 
Overall, although there is clear evidence for variation in evolutionary rates 250 
between different regions of the POU1F1 sequence, there is rather little evidence 251 
for rate variation between groups and species (Table 1). The rate (dN/dS) for 252 
Xenarthra is relatively low (Table 1), though sequences for only two species 253 
(armadillo and sloth) are available for this Eutherian superorder.  254 
 255 
A species for which the rate of evolution is relatively high, as noted above, is the 256 
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dog.  Sequences for wolf and domestic dog breeds were identical. This was 257 
studied further by examining the sequences of a number of species closely related 258 
to dog (family Canidae; fox, Vulpes and dhole, Cuon). The data for these 259 
additional species were incomplete, but did show POU1F1 sequences similar to 260 
that of dog, indicating that accelerated POU1F1 evolution occurred on the 261 
lineage leading to Canidae (given that sequences of other Caniformia - bear, 262 
panda and ferret - were conserved) (Supplementary Fig. 2). The phylogenetic 263 
trees shown in Fig. 3, based on dN and dS values, illustrate this.  GH and 264 
prolactin, expression of which is controlled by POU1F1, show a markedly 265 
episodic pattern of evolution, but interestingly for these proteins the lineage 266 
leading to Canidae does not show accelerated evolution (Li et al., 2005; Wallis 267 
1996, 2008; Wallis et al., 2000). The increased rate of POU1F1 evolution on the 268 
branch leading to dog, was confined to the TAD, hinge region and N-terminal 269 
part of the POU-specific domain (encoded by exons 1-3), but whether it was due 270 
to adaptive change or loss of function could not be determined. 271 
 272 
3.3. Alternative splicing of the POU1F1 gene 273 
The POU1F1 gene product is subject to alternative splicing, giving a number of 274 
variant forms of the protein, some of which have already been discussed. The 275 
availability of transcriptomic data for a number of mammalian species enables 276 
the extent and nature of such alternative splicing to be examined. 277 
 278 
Alternative splicing of POU1F1 at the exon 1/exon 2 splice site (giving inclusion 279 
or exclusion of the -domain) was assessed for those species for which 280 
transcriptomic databases were available for pituitary tissue or cells. Results are 281 
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shown in Table 2. Expression levels for the -variant were low compared with 282 
the variant in which the -domain is excluded - lower than 5% in all species 283 
examined except rat (12.2%) and sooty mangabey (Cercocebus; 6.5%). The level 284 
was particularly low (0.38%) in dog. Notably the level in marmoset (1.9%) was 285 
comparable with that in several other species, despite the fact that production of 286 
functional -variant protein in marmoset is not possible, owing to a stop codon 287 
(see above).  The expression level seen for -domain in rat agrees closely with 288 
that originally reported by Theill et al. (1992) and Morris et al. (1992), who 289 
found a ratio of 1:7 for the variants including or excluding the -domain. 290 
However, the results found here suggest that the rat may be exceptional, with 291 
most other species examined showing much lower expression levels of the -292 
variant. 293 
 294 
In many species, additional variants caused by alternative splicing at the exon 295 
1/exon 2 junction were observed. In most cases their incidence was less than 1% 296 
that of the main variant. Exceptions were a variant in which the splice site was 6 297 
nucleotides into exon 2 (potentially producing a variant two amino acids shorter 298 
than normal; incidence 1-2% that of the normal variant in several species 299 
including human, cow and sheep) and a variant in which exon 2 is excluded (very 300 
rare except in the naked mole rat, Heterocephalus, where its incidence is about 301 
25% that of the normal variant). 302 
 303 
Bastos et al. (2006) reported POU1F1 splice variants in sheep in which exon 3, 304 
or exons 3-5 were lacking. Analysis of sheep pituitary transcriptomes revealed 305 
the presence of the former, at about 6% relative to the normal variant, but the 306 
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variant lacking exons 3-5 was not detected. The splice variant lacking exon 3 was 307 
detected at a similar level in cow, but at a much lower level (<1%) in rat, dog and 308 
human. 309 
 310 
3.4. Conclusions 311 
Previous work on POU1F1 concluded that the main domains identified within the 312 
protein are strongly conserved, while regions between these (hinge and linker 313 
regions) are more variable. The present survey of POU1F1 sequences derived for 314 
a large number of mammalian species generally confirms this, except for the -315 
domain, which is very variable. 316 
 317 
The variability of the -domain is reflected in a high dN/dS ratio - 0.91 for the 318 
POU1F1 alignment including representatives from all main mammalian groups 319 
(Subgroup 1; Table 1). This is close to the ratio expected for neutral evolution 320 
(1.0), suggesting that this domain is not subject to functional constraints, and 321 
may have no specific function. High dN/dS values (0.52-1.31) for the -domain 322 
were obtained for each of the main mammalian groups examined separately, with 323 
no value significantly different from 1.0. Lack of specific function for the -324 
domain is also supported by the observation that in a number of species stop 325 
codons or indels in the -domain would prevent production of a functional 326 
protein product, although the corresponding splice variant is produced (in 327 
marmoset anyway) at a level similar to that in other species. As reported 328 
previously (Diamond and Gutierrez-Hartmann, 1996) the 5'/N-terminal half of 329 
the -domain does seem to more be strongly conserved, but this reflects 330 
conservation at the DNA/RNA level, both synonymous and nonsynonymous 331 
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substitutions, so the high dN/dS ratio is maintained. 332 
 333 
Also of interest in the light of these results is a recent report of a human patient 334 
with combined pituitary hormone deficiency resulting from a POU1F1 mutation 335 
in which the shorter ("normal") splice variant is missing, but the -variant is 336 
retained, suggesting that the latter cannot substitute functionally for the former 337 
(Takagi et al., 2017) 338 
 339 
Although the -splice variant of POU1F1 clearly does have different biological 340 
properties from the shorter normal variant, the above observations suggest that its 341 
physiological significance is limited; in a few species a functional protein cannot 342 
be produced, and in others the very high variability of the -domain suggests lack 343 
of specific function. It is also notable that in most species for which data is 344 
available, transcriptional databases indicate that the incidence of -domain 345 
inclusion is low, comparable with retention of introns.  Overall the results 346 
obtained here are consistent with the idea that for POU1F1, in most species, 347 
there is a single main transcript with variants produced by alternative splicing 348 
being of little biological significance.  A similar situation may apply for many 349 
other genes where alternative splicing has been described (Tress et al., 2017).  350 
 351 
Funding 352 
 This research did not receive any specific grant from funding agencies in the public, 353 
commercial, or not-for-profit sectors. 354 
355 
 17 
References 356 
 357 
Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J., 1990. Basic 358 
local alignment search tool. J. Mol. Biol. 215, 403–410. 359 
 360 
Andersen, B., Rosenfeld, M.G., 2001. POU domain factors in the neuroendocrine 361 
system: lessons from developmental biology provide insights into human disease. 362 
Endocr. Rev. 22, 2-35. 363 
 364 
Bamberger, A.-M., Bamberger, C.M., Pu, L.-P., Puy, L.A., Loh, Y.P., Asa, S.L., 365 
1995.  Expression of pit-1 messenger ribonucleic acid and protein in the human 366 
placenta. J. Clin. Endocrinol. Metab. 80, 2021–2026. 367 
 368 
Bastos, E., Ávila, S., Cravador, A., Renaville, R., Guedes-Pinto, H., Castrillo, 369 
J.L., 2006.   Identification and characterization of four splicing variants of ovine 370 
POU1F1 gene. Gene 382, 12-19. 371 
 372 
Baumeister, H., Wegner, M., Richter, D., Meyerhof, W.,  2000.  Dual regulation 373 
of somatostatin receptor subtype 1 gene expression by Pit-1 in anterior pituitary 374 
GH3 cells. Mol. Endocrinol. 14, 255-271. 375 
 376 
Ben-Batalla, I., Seoane, S., Garcia-Caballero, T., Gallego, R., Macia, M., 377 
Gonzalez, L.O., Vizoso, F.,  Perez-Fernandez, R., 2010. Deregulation of the Pit-378 
1 transcription factor in human breast cancer cells promotes tumor growth and 379 
metastasis. J. Clin. Inv. 120, 4289-4302. 380 
 18 
 381 
Chen, R., Ingraham, H.A., Treacy, M.N., Albert, V.R., Wilson, L., Rosenfeld, 382 
M.G.,  1990. Autoregulation of pit-1 gene expression mediated by two cis-active 383 
promoter elements. Nature 346. 583-586. 384 
 385 
Cohen, L.E., Radovick, S., 2002. Molecular basis of combined pituitary hormone 386 
deficiences. Endocr. Rev. 23, 431-442. 387 
 388 
Delhase, M., Vergani, P., Malur, A., Hooghe-Peters, E.L., Hooghe, R.J. 1993. 389 
The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid 390 
tissues. Eur. J. Immunol. 23, 951–955. 391 
 392 
Delhase, M., Vila, V., Hooghe-Peters, E.L., Castrillo, J.L., 1995. A novel 393 
pituitary transcription factor is produced by alternative splicing of the human 394 
GHF-1/PIT-1 gene. Gene 155, 273-275. 395 
 396 
Diamond, S.E., Gutierrez-Hartmann, A., 1996.  A 26-amino acid insertion 397 
domain defines a functional transcription switch motif in Pit-1.  J. Biol. Chem. 398 
271, 28925-28932.  399 
 400 
Diamond, S.E., Gutierrez-Hartmann, A., 2000. The Pit-1 domain dictates active 401 
repression and alteration of histone acetylation of the proximal prolactin 402 
promoter. J. Biol. Chem. 275, 30977-30986. 403 
 404 
Ellestad, L.E., Porter, T.E.,  2013. Ras-dva is a novel Pit-1- and glucocorticoid-405 
 19 
regulated gene in the embryonic anterior pituitary gland. Endocrinology 154, 406 
308-319. 407 
 408 
Featherstone, K., White, M.R.H., Davis, J.R.E., 2012. The prolactin gene: a 409 
paradigm of tissue-specific gene regulation with complex temporal transcription 410 
dynamics. J. Neuroendocrinol. 24, 977-990. 411 
 412 
Fox, S.R., Jing, M.T.C., Casanova, J., Ye, Z.-S., Stanley, F., Samuels, H.H.,  413 
1990.  The homeodomain protein, Pit-1/GHF-1, is capable of binding to and 414 
activating cell-specific elements of both the growth hormone and prolactin gene 415 
promoters. Mol. Endocrinol. 4, 1069-1080. 416 
 417 
Gil-Puig, C., Seoane, S., Blanco, M., Macia, M., Garcia-Caballero, T., Segura, 418 
C., Perez-Fernandez, R., 2005. Pit-1 is expressed in normal and tumorous 419 
human breast and regulates GH secretion and cell proliferation. Eur. J. 420 
Endocrinol. 153, 335–344. 421 
 422 
Haugen, B.R., Wood, W.M., Gordon, D.F., Ridgway, E.C., 1993.  A thyrotrope-423 
specific variant of Pit-1 transactivates the thyrotropin  Promoter. J. Biol. Chem. 424 
268, 20818-20824. 425 
 426 
Herman, J.-P., Julien, N., Guillen, S., Enjalbert, A., Pellegrini, I., Franc, J.-L.,  427 
2012.  Research resource: A genome-wide study identifies potential new target 428 
genes for POU1F1. Mol. Endocrinol. 26, 1455-1463. 429 
 430 
 20 
Jonsen, M.D., Duval, D.L., Gutierrez-Hartmann, A.  2009.  The 26-amino acid -431 
motif of the Pit-1 transcription factor is a dominant and independent repressor 432 
domain. Mol. Endocrinol. 23, 1371-1384. 433 
 434 
Kelberman, D., Rizzoti, K., Lovell-Badge, R., Robinson, I.C.A.F., Dattani, M.T.,  435 
2009.  Genetic regulation of pituitary gland development in human and mouse. 436 
Endocr. Rev. 30, 790-829. 437 
 438 
Li, S., Crenshaw, E.B., Rawson, E.J., Simmons, D.M., Swanson, L.W., 439 
Rosenfeld, M.G., 1990. Dwarf locus mutants lacking three pituitary cell types 440 
result from mutations in the POU-domain gene pit-1. Nature 347, 528-533. 441 
 442 
Li, Y., Wallis, M., Zhang, Y.-P., 2005.  Episodic evolution of prolactin receptor 443 
gene in mammals: coevolution with its ligand. J. Mol. Endocrinol. 35, 411-419. 444 
 445 
Maddison, W.P., Maddison, D.R., 2016.  Mesquite: a modular system for 446 
evolutionary analysis.  Version 3.10.  http://mesquiteproject.org. 447 
 448 
Majumdar, S., Irwin, D.M., Elsholtz, H.P., 1996,  Selective constraints on the 449 
activation domain of transcription factor Pit-1. Proc. Natl. Acad. Sci. U.S.A. 93, 450 
10256-10261. 451 
 452 
Morris, A.E., Kloss, B., McChesney, R.E., Bancroft, C., Chasin, A., 1992. An 453 
alternatively spliced Pit-1 isoform altered in its ability to trans-activate. Nucl. 454 
Acids Res. 20, 1355-1361. 455 
 21 
 456 
Nowakowski, B.E., Maurer, R.A.,  1994.  Multiple Pit-1-binding sites facilitate 457 
estrogen responsiveness of the prolactin gene. Mol. Endocrinol. 8, 1742-1749. 458 
 459 
Radovick, S., Nations, M., Du, Y., Berg, L.A., Weintraub, B.D., Wondisford, 460 
F.E., 1992. A mutation in the POU-homeodomain of Pit-1 responsible for 461 
combined pituitary hormone deficiency. Science 257, 1115-1118. 462 
 463 
Sánchez-Pacheco, A., Peña, P., Palomino, T., Güell, A., Castrillo, J.L., Aranda, 464 
A.,  1998.  The transcription factor GHF-1, but not the splice variant GHF-2, 465 
cooperates with thyroid hormone and retinoic acid receptors to stimulate rat 466 
growth hormone gene expression. FEBS Lett. 422, 103-107. 467 
 468 
Scully, K.M., Jacobson, E.M., Jepsen, K., Lunyak, V., Viadiu, H., Carrière, C., 469 
Rose, D.W., Hooshmand, F., Aggarwal, A.K., Rosenfeld, M.G., 2000. Allosteric 470 
effects of Pit-1 DNA sites on long-term repression in cell type specification. 471 
Science 290, 1127-1131. 472 
 473 
Sporici, R,A,, Hodskins, J.S., Locasto, D.M., Meszaros, L.B., Ferry, A.L., 474 
Weidner, A.M., Rinehart, C.A., Bailey, J.C., Mains, I.M., Diamond, S.E.,  2005.  475 
Repression of the prolactin promoter: a functional consequence of the 476 
heterodimerization between Pit-1 and Pit-1. J. Mol. Endocrinol. 35, 317-331. 477 
 478 
Takagi, M., Kamasaki, H., Yagi, H., Fukuzawa, R., Narumi, S., Hasegawa, T.,  479 
2017.  A novel heterozygous intronic mutation in POU1F1 is associated with 480 
 22 
combined pituitary hormone deficiency. Endocr. J. 64, 229-234. 481 
 482 
Theill, L.E., Castrillo, J.-L., Wu, D., Karin, M., 1989. Dissection of functional 483 
domains of the pituitary-specific transcription factor GHF-1. Nature 342, 945-484 
948. 485 
 486 
Theill, L.E., Hattori, K., Lazzaro, D., Castrillo, J.-L., Karin, M.,  1992. 487 
Differential splicing of the GHF1 primary transcript gives rise to two 488 
functionally distinct homeodomain proteins. EMBO J. 11, 2261-2269. 489 
 490 
Tress, M.L., Abascal, F., Valencia, A.,  2017. Alternative splicing may not be the 491 
key to proteome complexity. Trends Biochem. Sci. 42, 98-110. 492 
 493 
Wallis, M., 1996.  The molecular evolution of vertebrate growth hormones: a 494 
pattern of near-stasis interrupted by sustained bursts of rapid change.  J. Mol. 495 
Evo.  43, 93-100. 496 
 497 
Wallis, M., 2008. Mammalian genome projects reveal new growth hormone 498 
(GH) sequences.  Characterization of the GH-encoding genes of armadillo 499 
(Dasypus novemcinctus), hedgehog (Erinaceus europaeus), bat (Myotis 500 
lucifugus), hyrax (Procavia capensis), shrew (Sorex araneus), ground squirrel 501 
(Spermophilus tridecemlineatus), elephant (Loxodonta africana), cat (Felis 502 
catus) and opossum (Monodelphis domestica). Gen. Comp. Endocrinol. 155, 503 
271-279. 504 
 505 
 23 
Wallis, O.C., Mac-Kwashie, A.O., Makri, G., Wallis, M.,  2005.  Molecular 506 
evolution of prolactin in primates. J. Mol. Evo. 60, 606-614. 507 
 508 
Yang, Z., 2007. PAML 4: phylogenetic analysis by maximum likelihood. Mol. 509 
Biol. Evo. 24. 1586–1591. 510 
 511 
512 
 24 
Legends for Figures 513 
 514 
Fig. 1.  Overall structure of POU1F1.  The domains of the protein are indicated 515 
by alternating thick and thin lines. The -domain is shown in grey. Numbers 516 
above indicate amino acid residue numbers within the protein. Numbers below 517 
indicate the distribution of the 6 exons of the POU1F1 gene; 5' utr and 3' utr 518 
extensions of exons 1 and 6 are not included. 519 
 520 
Fig. 2. Sequence alignment of selected -domains.  A) Nucleotide sequences. B) 521 
Derived amino acid sequences. The full sequence for human -domain is shown 522 
on the top line; for sequences of other species . indicates identity to human.  523 
Positions where indels lead to changes in reading frame are shaded light grey 524 
(Cja, Smi, Mpe); for Mpe an insertion of GC occurs in the position indicated. 525 
Locations of stop codons are indicated by dark grey shading. Two additional 526 
marmoset species (Callithrix kuhlii, C. geoffroyi) had identical sequence to Cja. 527 
Full species names and common names are given to the right of the amino acid 528 
sequences. 529 
 530 
Fig. 3. Phylogenetic trees for selected POU1F1 coding sequences (subgroup 1) 531 
based on dS and dN values. The trees were derived using coding sequences 532 
excluding -domain. Numbers on selected branches are dN/dS ratios; note the 533 
accelerated evolution on the branch leading to dog (Clu). The overall dN/dS ratio 534 
for this sequence set was 0.055 (Table 1); that for the branch leading to dog was 535 
0.147. Full species names are as in Figure 2B plus Can Colobus angolensis 536 
(colobus monkey), Bac Balaenoptera acutorostrata (minke whale),   Bbu 537 
 25 
Bubalus bubalis (water buffalo),   Uma Ursus maritimus (polar bear),   Lwe 538 
Leptonychotes weddellii (Weddell seal), Pva Pteropus vampyrus (large flying 539 
fox), Mbr Myotis brandtii (Brandt's bat), Ete Echinops telfairi (Madagascar 540 
hedgehog).   Scale bars indicate substitutions/nucleotide site. 541 
 542 
 543 
544 
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Table 1 545 
 546 
 Rates of evolution (dN/dS) for sequences encoding the domains of POU1F1. 547 
                                                                                                                                                                                                                                                                                  548 
Domain   Subgroup 1* Primates** Glires   Laurasiatheria Afrotheria Xenarthra Marsupials   Monotremes 549 
                                                                                                                                                                                                                                                                                  550 
 551 
full CDS including  domain 0.085 0.085 0.083 0.079 0.077 0.037 0.101 0.128   552 
full CDS excluding  domain 0.055 0.048 0.055 0.051 0.038 0.013 0.093 0.084  553 
 554 
TAD   0.084 0.078 0.139 0.081 0.032 0.029 0.167 0.216 555 
 556 
-domain   0.907 1.255 1.308 1.011 0.789 0.524 0.812 0.987 557 
 558 
hinge region   0.146 0.111 0.106 0.113 0.211 0.044 0.172 0.286 559 
 560 
POU specific   0.008 0.007 0.003 0.003 0.000 0.000 0.021 0.000 561 
 562 
Linker region   0.052 0.052 0.057 0.078 0.124 0.000 0.103 0.000 563 
 564 
Homeodomain  0.017 0.023 0.023 0.014 0.005 0.000 0.024 0.001 565 
                                                                                                                                                                                                                                                                                  566 
* including representatives of main mammalian groups (Group 1; see Fig. 3 for species included in this 567 
group) 568 
** including tree shrew and flying lemur 569 
 570 
571 
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Table 2 572 
 Alternative splicing at the POU1F1 exon 1-exon 2 junction 573 
                                                                                                                                                                                                                                                                                  574 
Species Project tissue expts
a
 n
b
 % -domainc SEMd 
                                                                                                                                                                                                                                                                                  
Primates 
 
Homo sapiens SRP035346 pituitary 
adenoma 
9 3786 2.5 0.63 
Pan troglodytes SRP051959 pituitary 1 860 2.8  
Macaca spp
e
 SRP051959, 
SRP048677 
pituitary 6 5744 3.9 0.51 
Cercocebus atys SRP051959 pituitary 1 345 6.5  
Papio anubis SRP051959 pituitary 1 965 2.7  
Chlorocebus sabaeus SRP033127 pituitary 5 4592 3.0 0.11 
Callithrix jacchus SRP051959 pituitary 1 375 1.9  
       
Rodentia       
Rattus norvegicus SRP017586, 
SRP075804 
pituitary cells 
GH4C1 cells 
3 1272 12.2 1.45 
Heterocephalus glaber SRP061363 pituitary 1 173 1.2  
       
Cetartiodactyla       
Bos taurus SRP070150 pituitary 10 1584 2.3 0.48 
Bos taurus SRP052656 pituitary 5 866 4.2 0.10 
Ovis aries ERP005642 pituitary 11 2501 4.3 0.67 
Capra hircus SRP069238 pituitary 4 146 3.9 2.22 
       
Carnivora       
Canis lupus SRP055477 pituitary 4 733 0.4 0.23 
Ailuropoda melanocota SRP063482 pituitary 1 247 1.2  
 575 
a)  number of separate experiments for this species in this project 576 
b)  total hits including exon1-exon2 border 577 
c)  mean % -domain for the number of experiments shown (calculated for each experiment as hits 578 
including -domain as percentage of all hits including exon1-exon2 border) 579 
d)  SEM calculated where number of experiments is 3 or more 580 
e)  data from 4 different Macaca species 581 
 582 
583 
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 584 
Fig.1 585 
 586 
 587 
 588 
 589 
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Fig.2 591 
(A)  Nucleotide sequences 
 
Hsa        GTCCCATCTATTTTGTCTTTGATCCAAACTCCTAAATGTTTGTGCACACATTTCTCGGTGACAACGTTGGGAAACACA 
Nle        .............................................................................. 
Mmu        ...............................................G.......T...................... 
Sbo        .................................G............................................ 
Cja        ......................C..........G........C..C...........-.......A.......--... 
Smi        ......................C..........G........C................C.............--... 
Tsy        .....G............................TG.A....C....C.......T........T.A........G.. 
Mmur       ...TTGC................T..................C.........C........A................ 
Oga        ...TTG..C..............T.......T.......C..C......T..C.....CA.A...CC........G.. 
Dma        ...TTG.................TT.................CA........C..T..C..A................ 
Gva        .....G...G.............................C.....G..............G.............T... 
Tch        .....G.................................................T......G.T...C..G...... 
Itr        .....G..................................C.......T.......T.................T... 
Hgl        ..........................................CA..TGT.....C.............T......G.. 
Mau        .....G....................................CA...GT................TA.......T... 
Fda        ..........................................CT..TGT.....C.............T......G.. 
Nga        ..........................................CA....T..G.T...........TA.......T... 
Jja        ....T.........................T.....CA....CA..A.T....A.T.........TA.......TT.. 
Rno        .....G....................................CA....T........A........A.......T... 
Mmus       .....G............................C.......CA...GT........A........A.......T... 
Cpo        .CG.ATCTAT................C.T............TCA....T.....GT...................... 
Ocu        ..........................................CA.........G.T.....TG.T.....A....... 
Ttr        .....G..........................................T......T.........A............ 
Cdr        .....G...G.............T........................T......T......G..AC........... 
Ssc        .....G...........................C.....C........T......T.........AC........... 
Oar        .....G..........................................TG...TGT....G....A.........G.. 
Bmu        .....G..........................................TG...TGT........T.C........... 
Fca        ............................................TG..T.....CT.......T.............. 
Clu        .....G..........T.........................CATG..T......T........T.---......... 
Mpu        .....G..........................................T....T........................ 
Eca        .....G.........................................GT............................. 
Mlu        .......................T......T.......C...C.T...T.....C...............A....... 
Efu        .......................T......T.......C...C.T...T.....C...............A....... 
Eeu        .....G....................................CA...GT...........G.G.TACC.......... 
Ccr        .....G...G.........................T..C.........T......G.........AC........... 
Sar        .....G...............................A....CA...GT...................T......... 
Mpe        .....G....................................CA....T......T...................... 
Dno        .....G....................................CA..T.T.........CA.....T.....T...... 
Tma        .....G....................................CA..T..................T............ 
Laf        .....G....................................C...T........T.........T............ 
Cas        ....................A......................A.....T...............T............ 
Eed        .AT.T..T.T....TC...CA...T......T.........C.A..T..GC---.T........TT..T......... 
Oaf        ....................A....................ACA....A......T......G.TT........T... 
Sha        .....G...............................T..C.CA..TG........CA.......T..T.....T... 
Mdo        .....G...............................T..C.CA..TG........CA.......T..T......G.. 
Oan        ...T...T.G.....C..G..G.......A---.......C.CATGTG..C.....CT..GA...TC.......TG.. 
 
 
(B) Protein sequences 
 
Hsa    VPSILSLIQTPKCLCTHFSVTTLGNT    Homo sapiens        human       
Nle    ..........................    Nomascus leucogenys        gibbon      
Mmu    ..................L.......    Macaca mulatta        rhesus monkey   
Sbo    ...........E..............    Saimiri boliviensis        squirrel monkey  
Cja    .......T...E..RP...-....-.    Callithrix jacchus        marmoset         
Smi    .......T...E..R.........-.    Saguinas midas        tamarin         
Tsy    ...........MY.R...L..MM..A    Tarsius syrichta        tarsier        
Mmur   .LP...........R..S..K.....    Microcebus murinus        mouse lemur        
Oga    .L........L...R.LS.AK....A    Otolemur garnettii        galago        
Dma    .L......*.....H..SLAK.....    Daubentonia madagascariensis aye aye        
Gva    ...V...........A....A.....    Galeopterus variegatus       flying lemur       
Tch    ..................L..MF...    Tupaia chinensis        tree shrew        
Itr    .............S..Y.........    Ictidomys tridecemlineatus   ground squirrel    
Hgl    ..............HMY.P...F..A    Heterocephalus glaber        naked mole rat     
Mau    ..............H.Y.....M...    Mesocricetus auratus        golden hamster     
Fda    ..............LMY.P...F..A    Fukomys damarensis        Damara mole rat    
Nga    ..............H.YV....M...    Nannospalax galili        Galili mole rat    
Jja    .L........S.H.HKYLL...M..S    Jaculus jaculus        jerboa      
Rno    ..............H.Y..M..M...    Rattus norvegicus        rat         
Mmus   ...........T..H.Y..M..M...    Mus musculus         mouse       
Cpo    AHLF....HI...FH.Y.V.......    Cavia porcellus        guinea pig        
Ocu    ..............H..LL.MM.E..    Oryctolagus cuniculus       rabbit        
Ttr    ................Y.L.......    Tursiops truncatus        dolphin        
Cdr    ...V............Y.L.......    Camelus dromedarius        camel       
Ssc    ...........Q....Y.L.......    Sus scrofa         pig         
Oar    ................C.V.A....A    Ovis aries         sheep       
Bmu    ................C.V..M....    Bos mutus         yak         
Fca    ...............AY.L..S....    Felis catus         cat         
Clu    .....F........HAY.L..M-...    Canis lupus         dog         
Mpu    ................Y.........    Mustela putorius        ferret        
Eca    ................Y.........    Equus caballus        horse       
Mlu    ..........S...R.Y.P....E..    Myotis lucifugus        little brown bat   
Efu    ..........S...R.Y.P....E..    Eptesicus fuscus        big brown bat      
Eeu    ..............H.Y...AIP...    Erinaceus europaeus        european hedgehog  
Ccr    ...V.......N....Y.W.......    Condylura cristata        star-nosed mole    
Sar    ............Y.H.Y.....F...    Sorex araneus         shrew         
Mpe    ..............H.Y.L.......    Manis pentadactyla        pangolin        
Dno    ..............HIY..A......    Dasypus novemcinctus        armadillo        
Tma    ..............HI..........    Trichechus manatus        manatee        
Laf    ..............RI..L.......    Loxodonta africana        elephant        
Cas    ..............Y.L.........    Chrysochloris asiatica       golden mole        
Eed    DLFFFPS.*.L..FYIR-L..IF...    Elephantulus edwardii        elephant shrew    
Oaf    ..............H.N.L..I....    Orycteropus afer        aardvark        
Sha    ............FSHM...M..F...    Sarcophilus harrisii         Tasmanian devil    
Mdo    ............FSHM...M..F..A    Monodelphis domestica        opossum        
Oan    .SFV.PVV..-..SHV...LE....A    Ornythorhynchus anatinus     platypus        
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Fig.3 595 
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